中国药物经济学2024，Vol.19Issue(8)：89-91,95,4.DOI:10.12010/j.issn.1673-5846.2024.08.019
脉管复康片辅助治疗对恢复期脑梗死患者肢体功能及认知功能的影响
The Effect of Auxiliary Treatment with Maiguan Fukang Tablets on Limb Function and Cognitive Function in Patients with Convalescent Cerebral Infarction
麦永佳 1李伟信 1刘红玉2
作者信息
- 1. 廉江市人民医院神经内二科,广东湛江 524400
- 2. 廉江市妇幼保健院中医科,广东湛江 524499
- 折叠
摘要
Abstract
Objective To explore the effect of vascular rehabilitation tablets on limb function and cognitive function in patients with convalescent cerebral infarction.Methods A total of 93 convalescent cerebral infarction patients admitted to Lianjiang People's Hospital from March 2022 to April 2023 were selected as the study objects and divided into control group(47 cases)and observation group(46 cases)according to random number table method.The control group was treated with routine treatment,and the observation group was treated with Maiguanfukang tablet on the basis of routine treatment.The clinical efficacy,limb function,cognitive function,coagulation index and adverse reactions were compared between the two groups.Results The effective rate of the observation group was higher than that of the control group(P＜0.05).After 14 days of treatment,the scores of simplified Fugl-Meyer Motor Function Rating Scale(FMA),Berg Balance Scale(BBS)and Montreal Cognitive Assessment Scale(MoCA)in the observation group were higher than those in the control group,and the levels of D-dimer(D-D)and fibringen(FIB)were lower than those in the control group,with statistical significance(P＜0.05).There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P＞0.05).Conclusion In convalescent cerebral infarction patients,Maiguanfukang tablets can improve limb function and cognitive function,regulate coagulation index,and have high safety.关键词
脑梗死/恢复期/脉管复康片/肢体功能/认知功能Key words
Cerebral infarction/Recovery period/Vascular rehabilitation tablets/Limb function/Cognitive function分类
医药卫生引用本文复制引用
麦永佳,李伟信,刘红玉..脉管复康片辅助治疗对恢复期脑梗死患者肢体功能及认知功能的影响[J].中国药物经济学,2024,19(8):89-91,95,4.
